Mochi Health's combined membership-plus-medication structure commonly totals more per month than a flat-rate compounded provider charging for medication and care together.
Luma Health's compounded semaglutide ($197/month) and tirzepatide ($297/month) are priced as one flat number — no separate membership fee to add on top.
When patients compare "cheapest GLP-1 provider" options, Mochi Health often comes up because of its recognizable brand and app-based model. But comparing Mochi fairly against a flat-rate provider requires looking at the full monthly total, not just the headline medication price.
How Mochi Health's Pricing Is Structured
Mochi Health's model separates a membership fee (commonly reported around $79/month) from the medication cost itself, which is billed on top. Combined, patients have reported total monthly costs in the range of roughly $175-$230+/month depending on the specific medication and dose. It's worth confirming the current membership fee and medication pricing directly with Mochi Health, since both figures can change fairly frequently.
This two-part billing structure means the advertised membership fee alone doesn't tell you what you'll actually pay each month. Patients researching Mochi Health specifically sometimes anchor on the lower membership number and are later surprised by the combined total once medication cost is added on top of it entirely.
The membership fee itself covers provider access, dose management, and the app-based communication tools discussed further below. Understanding what specifically the membership fee pays for helps clarify whether that portion of the cost is delivering value proportional to what a comparable flat-rate provider bundles into a single, simpler number without the same monthly recurring charge.
It's also worth noting that Mochi Health's specific fees and structure, like most providers in this fast-moving industry, can shift over time as the broader compounded GLP-1 market continues to evolve. Checking the current published pricing directly on Mochi's own site, rather than relying on figures from an older article or review, is the most reliable way to get an accurate picture of current costs before making any enrollment decision based on cost.
How a Flat-Rate Model Compares
A flat-rate compounded provider simply folds the entire medical evaluation, ongoing provider access, and medication itself into a single simple number, with no separate membership layer added on top. Luma Health's $197/month semaglutide and $297/month tirzepatide are priced this way — the number you see is the number you pay, regardless of dose level, with no membership fee added separately.
This structural difference matters most specifically at higher doses during titration. As your dose increases during titration, a membership-plus-medication model can see its total cost rise accordingly, while a flat-rate model stays fixed regardless of which specific dose you're taking. Patients who expect to reach a higher maintenance dose during treatment should factor this trajectory into their comparison from the start, not just the initial starting-dose price.
Running the actual math over a full year of treatment at your expected maintenance dose, rather than comparing starting prices alone, is the only reliable way to determine which structure is genuinely less expensive for your specific treatment course. A membership-plus-medication model that looks competitive at a low starting dose can become considerably more expensive once you've titrated to an effective, ongoing maintenance dose.
It's worth building this comparison as a simple spreadsheet exercise: list out your expected monthly cost under each provider at your target dose, multiply by twelve for an annual figure, and add any known add-on fees discussed further below. This concrete exercise takes only a few minutes but provides considerably more clarity than comparing advertised headline numbers that may not reflect your actual total cost once dose and any additional fees are factored in.
The most common mistake when comparing "cheapest" providers is comparing a membership fee against an all-inclusive price, or vice versa. Before deciding, add up everything you'd actually pay each month at your expected dose — membership plus medication plus any add-on fees — for a true side-by-side comparison.
Watching for Lab Work and Other Add-On Fees
Beyond the headline membership and medication figures, it's worth asking any provider directly whether lab work, a specific delivery fee, or a required annual check-in carries an additional charge beyond the advertised monthly total. These add-on costs are easy to miss during initial signup and can meaningfully change the real total cost comparison between two providers whose advertised prices look similar at first glance.
A useful habit before enrolling with any provider is asking for a complete, itemized breakdown of every possible charge you might encounter over a full year of treatment, not just the single recurring monthly figure listed prominently on the pricing page. This single question tends to surface any add-on fees that wouldn't otherwise be obvious from the provider's main pricing page or marketing materials aimed specifically at attracting new patients with an appealing headline price.
Shipping fees in particular are worth confirming explicitly upfront, since some providers include shipping in the advertised monthly price while others charge it separately per individual delivery. Over a full year, a small per-shipment fee can add up to a meaningful sum, and it's exactly the kind of detail that's easy to overlook when comparing two providers' advertised prices side by side without carefully digging into the fine print of each provider's specific terms.
What You're Getting for Mochi's Membership Fee
Mochi Health's app-based model includes provider messaging, dose management, and account tools accessible through its mobile app, which some patients specifically value for the interface and convenience. If that app experience is genuinely important to you, it's a real factor to weigh against the cost difference — not every patient's priorities are purely about the lowest total price.
It's worth being honest about how much you'll actually use a dedicated app interface versus a simpler web-based or messaging-based system, since a polished app is a genuine convenience for some patients but adds no clinical value beyond what a more basic communication channel provides for dose adjustments and side-effect questions.
Some patients specifically appreciate the structured, app-based tracking and reminders that come with this kind of model, since it can help maintain consistency with dosing schedules and appointment follow-ups. Others find a simpler system, without an additional app to manage, is preferable and reduces the number of platforms they need to check regularly for updates about their care and treatment progress.
If app-based tracking is genuinely a priority for you, it's worth asking specifically what features the app provides beyond basic messaging — dose reminders, side-effect logging, progress tracking, or direct integration with wearable fitness devices are all meaningfully different feature sets that could factor heavily into your final decision between providers.
Verifying Either Provider Before Enrolling
Whichever model you're leaning toward specifically, take a few minutes to confirm the specific compounding pharmacy each provider uses and that pharmacy's current state licensing, independently through that state's board of pharmacy website rather than relying solely on marketing claims. Both compounded semaglutide and tirzepatide require a documented individual clinical justification following the 2024-2025 shortage resolutions, not simply cost or convenience alone, so it's also reasonable to ask directly what specific clinical basis a provider maintains for prescribing compounded rather than brand-name medication.
This verification step matters regardless of which pricing structure you ultimately choose, since a lower price from a provider operating outside current compliance standards isn't actually a better deal — it's a different kind of risk that a simple cost comparison doesn't capture. A few minutes of verification upfront is a small price to pay for genuine peace of mind about the medication you'll be taking regularly over an extended treatment course spanning many months or longer.
It's also reasonable to ask either provider for a certificate of analysis confirming a specific batch's potency and purity, since a legitimate, quality-focused compounding pharmacy should be able to provide this information on request without hesitation or excessive delay. This isn't standard practice everywhere across the industry, but a provider's genuine willingness to accommodate the request is itself a useful signal about their overall transparency and quality standards more broadly.
Which Model Fits You
The right choice depends on whether the app experience and any additional membership features Mochi provides are genuinely worth the added cost to you, or whether you'd rather pay a single flat number and manage everything through simpler, more direct communication with your provider. Patients who value structured app-based tracking and are willing to pay for it should weigh that preference honestly against the pure cost savings a flat-rate model can offer without any app-based tracking layer included.
- Specifically value its app-based interface and experience
- Aren't primarily optimizing for the lowest possible monthly total
- Are comfortable with a membership-plus-medication billing structure
- Want the simplest possible monthly total to budget around
- Don't need a specific app experience to feel supported
- Want pricing that doesn't change as your dose increases
One number.
No membership fee added on top.
Compounded semaglutide at $197/month or tirzepatide at $297/month — medical evaluation, provider visits, and shipping all included.
Get Started → Or start your free health assessmentFrequently Asked Questions
Yes, according to publicly reported information, Mochi Health charges a membership fee (commonly around $79/month) separately from the medication cost itself.
Combined totals have been reported in the roughly $175-$230+/month range depending on medication and dose. Always verify current specific pricing directly with Mochi before enrolling.
A flat-rate provider like Luma Health folds everything into one number ($197/month semaglutide, $297/month tirzepatide) with no separate membership fee, which can be lower than a combined membership-plus-medication total.
No, when both prescribe compounded semaglutide or tirzepatide, the active ingredient and clinical mechanism are the same regardless of which platform prescribes it. What differs is pricing structure and support model.
Your full expected monthly total at your target dose, including any membership fees, not just the advertised starting medication price.
That depends on your personal priorities. If the app experience genuinely adds value for you, it may justify a higher total cost; if not, a flat-rate provider without that layer may be the more efficient choice.
Ask directly about lab work, delivery fees, or required annual check-ins that might carry an additional charge. These can meaningfully change the total cost comparison between providers.
Often yes, since medication cost is typically billed separately and can rise with dose. A flat-rate model, by contrast, stays fixed regardless of which specific dose you're taking.
Yes. Confirm the specific pharmacy's state license independently through that state's board of pharmacy website, and ask what documented clinical justification applies to your prescription, rather than relying solely on a provider's marketing claims.
Not always. Some providers bundle shipping into the monthly price while others charge it separately per delivery, which can add up meaningfully over a full year of treatment. Confirm this directly before enrolling.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed 33567185
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed 35658024
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov